Role of Cardiac Sub-Structure (CSS) Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)

被引：0
|
作者：
Dulling, T. J. [1 ]
Allen, A. [2 ]
Edrich, O. [3 ]
Lee, D. H. [4 ]
Money, D. [5 ]
Eichelberger, G. [6 ]
Kumar, A. [6 ]
Cruz-Chamorro, R. J. [7 ]
El Naqa, I. [8 ]
Bryant, J. M. [9 ]
Keit, E. [10 ]
Feygelman, V. [7 ]
Dudas, D. [11 ]
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[2] Univ S Florida, Sch Med, Tampa, FL USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Dept Machine Learning, Tampa, FL USA
[4] Morsani Coll Med, Div Cardiovasc Med, Tampa, FL USA
[5] Morsani Coll Med, Dept Internal Med, Tampa, FL USA
[6] Duke Univ Med Ctr, Dept Radiat Oncol, Durham, NC USA
[7] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[8] H Lee Moffitt Canc Ctr & Res Inst, Dept Machine Learning, Tampa, FL USA
[9] Univ S Florida, Tampa, FL USA
[10] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[11] Czech Tech Univ, Fac Nucl Sci & Phys Engn, Prague, Czech Republic
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 120卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2032
引用
收藏
页码：E16 / E17
页数：2
相关论文
共 50 条
  • [1] Role of Whole-Heart Dose on Overall Survival (OS) in Locally-Advanced Non-Small Cell Lung Cancer (LA-NSCLC) Patients (Pts) Treated with Concurrent Definitive Chemoradiotherapy (CDCRT)
    Dilling, T. J.
    Allen, A.
    Edrich, O.
    Dudas, D.
    Money, D.
    Eichelberger, G.
    Kumar, A.
    Bryant, J. M.
    Cruz-Chamorro, R. J.
    El Naga, I.
    Keit, E.
    Feygelman, V.
    Lee, D. H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E16 - E16
  • [2] Machine Learning Analysis of Cardiac Sub-Structure Dose and Overall Survival of NSCLC Pts Treated with Concurrent Definitive Chemoradiotherapy
    Dilling, T. J.
    Allen, A.
    Edrich, O.
    Dudas, D.
    Lee, D. H.
    Money, D.
    Eichelberger, G.
    Kumar, A.
    Bryant, J. M.
    Cruz-Chamorro, R. J.
    Keit, E.
    Feygelman, V.
    Scott, E.
    Rosenberg, S. A.
    El Naqa, I.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S585 - S586
  • [3] Concurrent chemoradiotherapy (cCTRT) for locally-advanced, unresectable non-small cell lung cancer (LA-NSCLC): A national survey of current practice
    Helbrow, J.
    Bayman, N.
    MacNicoll, F.
    Faivre-Finn, C.
    LUNG CANCER, 2012, 75 : S50 - S51
  • [4] A pilot study of a decision aid for patients with locally-advanced non-small cell lung cancer (LA-NSCLC)
    Brundage, MD
    Cosby, RH
    Feldman-Stewart, D
    Gregg, R
    Dixon, P
    Youssef, Y
    Mackillop, WJ
    MEDICAL DECISION MAKING, 1998, 18 (04) : 483 - 483
  • [5] Association of Cardiac Dose with Cardiac Events and Survival for Locally Advanced Non -Small Cell Lung Cancer (LA-NSCLC) Treated with Concurrent Chemoradiotherapy (cCRT) in the Era of Immune Checkpoint Inhibitor (ICI) Consolidation
    Yegya-Raman, N.
    Lee, S. H.
    Friedes, C.
    Iocolano, M.
    Kim, K. N.
    Duan, L.
    Li, B.
    Sun, L.
    Cohen, R.
    Cengel, K. A.
    Levin, W. P.
    Langer, C.
    Aggarwal, C.
    Ky, B.
    O'Quinn, R. P.
    Zou, W.
    Teo, K.
    Deasy, J. O.
    Xiao, Y.
    Feigenberg, S. J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S169 - S170
  • [6] Cardiac Toxicity after Definitive Standard Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
    Mankuzhy, N.
    Quinn, T. J.
    Ye, H.
    Grills, I. S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E518 - E519
  • [7] Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC)
    Xueru Zhu
    Runping Hou
    Xiaoyang Li
    Chang Jiang
    Wuyan Xia
    Xiaolong Fu
    Radiation Oncology, 15
  • [8] Predictive model of the first failure pattern in patients receiving definitive chemoradiotherapy for inoperable locally advanced non-small cell lung cancer (LA-NSCLC)
    Zhu, Xueru
    Hou, Runping
    Li, Xiaoyang
    Jiang, Chang
    Xia, Wuyan
    Fu, Xiaolong
    RADIATION ONCOLOGY, 2020, 15 (01)
  • [9] Phase II trial of concurrent erlotinib in locally advanced non-small cell lung cancer (LA-NSCLC)
    Hansen, O.
    Knap, M.
    Khalil, A.
    Nyhus, C.
    Brink, C.
    Hoffmann, L.
    Schytte, T.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S663 - S663
  • [10] Toxicities and compliance to treatment in locally advanced non-small cell lung cancer (LA-NSCLC) treated with concurrent chemoradiotherapy (cCTRT) at the Christie NHS Foundation Trust
    Mehmood, Q.
    Ashcroft, L.
    Bayman, N.
    Blackhall, F.
    Burt, P.
    Chittalia, A.
    Coote, J.
    Fenemore, J.
    Halkyard, E.
    Harris, M.
    Lee, L.
    Pemberton, L.
    Sheikh, H.
    Taylor, P.
    Faivre-Finn, C.
    LUNG CANCER, 2013, 79 : S63 - S64
12345